Detailed ppt on CKD for medical students
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Running Command
Writing File
Running Command
Running Command
Your CKD presentation is ready:
CKD Medical Students
Presentation · PPTX
29 slides with a navy/teal/amber color palette. Here's what's covered:
| # | Slide(s) | Content |
|---|---|---|
| 1 | Title | Title slide with source attribution |
| 2 | Learning Objectives | 7 core learning outcomes |
| 3–4 | Definition & Epidemiology | KDIGO definition, 5 epidemiology stats, key criteria |
| 5–7 | Classification | G1–G5 GFR table (color-coded), A1–A3 albuminuria, KDIGO heat map, CGA system explained |
| 8–10 | Etiology & Risk Factors | Top 5 causes with % prevalence, risk factor grid (NCDs, infectious, genetic, lifestyle) |
| 11–12 | Pathophysiology | Step-by-step hyperfiltration→sclerosis flow; RAS, proteinuria, FGF-23/Klotho, uremic toxins |
| 13–14 | Clinical Features | Stage-by-stage table from asymptomatic (G1) to uremic syndrome (G5) |
| 15–16 | Complications | CVD, anemia, CKD-MBD, metabolic - four-column layout |
| 17 | CKD-MBD Detail | FGF-23 → PTH cascade, bone types, treatment (phosphate binders, calcitriol, cinacalcet) |
| 18–19 | Diagnosis | Blood, urine, imaging, biopsy indications |
| 20–22 | Management | ACEi/ARB, SGLT-2i, diet; anemia management with ESA targets; drug dosing/nephrotoxins |
| 23–24 | RRT | AEIOU indications; HD vs PD vs transplant comparison |
| 25 | Drug Considerations | Dose adjustments + nephrotoxins to avoid |
| 26 | Referral Criteria | 8 triggers for nephrology referral with rationale |
| 27 | Key Trials | CREDENCE, DAPA-CKD, EMPA-KIDNEY, FIDELIO, RENAAL, REIN, DCCT/UKPDS |
| 28 | Summary | 7-point key takeaways |
| 29 | References | Harrison's 22E, Comprehensive Clinical Nephrology 7th Ed, Brenner & Rector, KDIGO 2012 |
Detailed chronic liver disease ppt for medical students
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Writing File
Running Command
Running Command
Your Chronic Liver Disease presentation is ready:
CLD Medical Students
Presentation · PPTX
27 slides with a deep forest green / amber / burgundy palette. Here's what's covered:
| # | Slide(s) | Content |
|---|---|---|
| 1 | Title | Title slide with textbook sources |
| 2 | Learning Objectives | 7 core outcomes |
| 3–4 | Definition & Epidemiology | KDIGO definition, compensated vs decompensated (median survival data), 5 global burden stats |
| 5–6 | Etiology | Top 6 causes with prevalence percentages and distinguishing features (ALD, NAFLD, HCV, HBV, PBC/PSC/AIH, hereditary) |
| 7–9 | Pathophysiology | Fibrosis cascade (TGF-β → HSC → collagen); portal hypertension HVPG thresholds (5/10/12/20 mmHg); hyperdynamic circulation |
| 10–12 | Clinical Features & Investigations | Symptoms, hepatic signs, peripheral signs, decompensated features; LFTs, haematology, serology, imaging/biopsy |
| 13–15 | Scoring — Child-Pugh & MELD | Full 5-parameter Child-Pugh table (A/B/C with survival data); MELD formula + 3-month mortality table; MELD-Na |
| 16–22 | Complications | Overview diagram (portal HTN vs liver insufficiency); ascites (4 grades + treatment ladder); variceal haemorrhage (prophylaxis + acute management); HE (West Haven Grade 0–IV table + pathophysiology); SBP vs HRS (side-by-side); HCC (risk/surveillance/BCLC staging/treatment) |
| 23–25 | Management | Disease-specific (alcohol/antivirals/NAFLD/AIH/PBC/PSC); general measures; liver transplantation (Milan criteria, King's criteria, contraindications, outcomes) |
| 26 | Summary | 7-point key takeaways |
| 27 | References | Harrison's 22E, Goldman-Cecil, Sleisenger & Fordtran, EASL Guidelines, BAVENO VII |
detailed ppt on CLD for medical students
I just created a detailed CLD presentation for you in the previous message! You can download it here:
CLD Medical Students
Presentation · PPTX
Here's a quick recap of what's inside (27 slides):
| Section | Slides | Topics |
|---|---|---|
| Definition & Epidemiology | 2 | KDIGO definition, compensated vs decompensated, global burden stats |
| Etiology | 1 | Top 6 causes (ALD, NAFLD, HCV, HBV, PBC/AIH, hereditary) with prevalence % |
| Pathophysiology | 3 | Fibrosis cascade (TGF-β → HSC), portal HTN (HVPG thresholds), hyperdynamic circulation |
| Clinical Features & Investigations | 2 | Symptoms, hepatic + peripheral signs, LFTs, serology, imaging |
| Severity Scoring | 2 | Full Child-Pugh table (A/B/C + survival), MELD formula + mortality table, MELD-Na |
| Complications | 6 | Varices, ascites (grading + treatment ladder), SBP, HRS, HE (West Haven 0–IV), HCC (BCLC staging) |
| Management | 2 | Disease-specific therapy + general measures |
| Transplantation | 1 | Milan criteria, King's criteria, contraindications, post-transplant outcomes |
| Summary + References | 2 | 7 key takeaways, Harrison's 22E / Goldman-Cecil / EASL Guidelines |
If you need any changes - different color scheme, additional slides on a specific topic, or a different format - just let me know!
Detailed ppt on valvular heart disease for medical students
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Running Command
Writing File
Running Command
Running Command
Your Valvular Heart Disease presentation is ready:
VHD Medical Students
Presentation · PPTX
25 slides with a deep crimson/maroon/gold palette. Here's what's covered:
| # | Slide(s) | Content |
|---|---|---|
| 1 | Title | Sources: Harrison's 22E, Braunwald's, Fuster & Hurst 15th Ed |
| 2 | Learning Objectives | 7 outcomes covering anatomy to intervention |
| 3–5 | Overview | Cardiac valve anatomy (all 4 valves); haemodynamic principles (stenosis vs regurgitation, acute vs chronic); ACC/AHA Staging A–D explained with clinical criteria |
| 6–9 | Aortic Stenosis | Etiology (calcific/BAV/rheumatic with % prevalence); pathophysiology cascade (LV pressure overload → concentric LVH → decompensation); clinical features + classic triad (SAD); echo severity table (AVA/gradient/velocity); SAVR vs TAVI comparison with PARTNER 3 / Evolut trial data |
| 10–11 | Aortic Regurgitation | Etiology (valve vs root); pathophysiology; 6 eponymous signs (Corrigan, de Musset, Quincke, etc.); Austin Flint murmur; echo criteria; valve-sparing surgery indications |
| 12–13 | Mitral Stenosis | Pathophysiology cascade (LAP → pulm. HTN → RVF → AF); Wilkins score; MVA severity; PBMV indications; acute decompensation triggers |
| 14–15 | Mitral Regurgitation | Primary vs secondary causes; papillary rupture; TEER/MitraClip (COAPT trial data); MV repair vs replacement; indications (EF/LVESD thresholds) |
| 16–17 | Right-sided Valve Disease | Tricuspid stenosis/regurgitation, pulmonary stenosis/regurgitation, carcinoid heart disease, Ebstein anomaly |
| 18–19 | Infective Endocarditis | Organisms; Modified Duke Criteria (major + minor); classic peripheral signs (Janeway, Osler's, Roth spots, splinters); management; prophylaxis |
| 20–21 | Prosthetic Valves | Mechanical vs bioprosthetic (types, durability, anticoagulation targets); INR targets by position; complications (thrombosis, IE, haemolysis, paravalvular leak) |
| 22 | Murmur Summary | Full 6-lesion auscultation table (timing/quality/location/radiation/extra features) |
| 23 | Dynamic Auscultation | Manoeuvre effects table (Valsalva, standing, squatting, inspiration, hand grip) — ↑/↓ for AS/AR/MS/MR/HOCM |
| 24 | Summary Table | All 4 major lesions side-by-side (mechanism/murmur/pulse/echo/treatment) |
| 25 | References | Harrison's 22E, 2021 ACC/AHA guideline, PARTNER 3, COAPT |
Detailed ppt on valvular heart disease for medical students
I just built this presentation for you in the previous message! Download it here:
VHD Medical Students
Presentation · PPTX
Here's a quick recap of the 25 slides (deep crimson/maroon/gold palette):
| Section | Slides | Topics Covered |
|---|---|---|
| Overview & Anatomy | 3 | All 4 valve structures; haemodynamic principles (stenosis vs regurgitation, acute vs chronic); ACC/AHA Staging A–D |
| Aortic Stenosis | 4 | Etiology (calcific/BAV/rheumatic + prevalence); LV pressure overload cascade; classic triad (SAD — Angina/Syncope/Dyspnoea); echo severity table; SAVR vs TAVI (PARTNER 3, Evolut) |
| Aortic Regurgitation | 2 | Valve vs root causes; eccentric LVH; 6 eponymous signs (Corrigan, de Musset, Quincke, etc.); Austin Flint murmur; valve-sparing surgery |
| Mitral Stenosis | 2 | LAP → pulm. HTN → RVF cascade; Wilkins score; PBMV criteria; decompensation triggers |
| Mitral Regurgitation | 2 | Primary vs secondary (organic vs functional); TEER/MitraClip (COAPT trial); MV repair thresholds |
| Right-sided Valves | 2 | Tricuspid stenosis/regurgitation; PS/PR; carcinoid heart disease; Ebstein anomaly |
| Infective Endocarditis | 2 | Organisms; Modified Duke Criteria; peripheral signs (Janeway/Osler/Roth); prophylaxis |
| Prosthetic Valves | 2 | Mechanical vs bioprosthetic; INR targets; complications (thrombosis, IE, haemolysis) |
| Auscultation Guides | 2 | Full 6-lesion murmur table + dynamic auscultation (Valsalva/squatting/inspiration/hand grip) |
| Summary + References | 2 | All 4 lesions side-by-side; 2021 ACC/AHA guideline + key trials |
If you'd like any modifications - additional slides, different color scheme, or extra topics (e.g. rheumatic fever, pregnancy and VHD, perioperative management) - just ask!
Detailed ppt on hepatitis for medical students
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Running Command
Writing File
Running Command
Running Command
Your Hepatitis presentation is ready:
Hepatitis Medical Students
Presentation · PPTX
22 slides with a deep amber/saffron/brown palette. Here's the full breakdown:
| # | Slide(s) | Content |
|---|---|---|
| 1 | Title | Sources: Harrison's 22E, Goldman-Cecil, Sleisenger & Fordtran |
| 2 | Learning Objectives | 7 clinical outcomes |
| 3–5 | Overview & Pathophysiology | Classification grid (viral/alcoholic/AIH/DILI); inflammatory cascade → fibrosis; 3 patterns (hepatocellular, chronic, cholestatic) |
| 6–7 | Hepatitis A | Serology (IgM vs IgG vs PCR); self-limiting course; fulminant risk groups; vaccine schedule; post-exposure prophylaxis |
| 8–9 | Hepatitis B | Virology; transmission routes; risk of chronicity by age at infection (90% neonates → < 5% adults); 5 phases of chronic HBV table (HBsAg/HBeAg/DNA/ALT/activity) |
| 10 | HBV Serology | Full 7-marker table (HBsAg, anti-HBs, anti-HBc IgM/IgG, HBeAg, anti-HBe, HBV DNA) with interpretation + clinical use |
| 11 | HBV Treatment | Treatment indications (HBeAg+/−, cirrhosis, pregnancy); drug table (TDF/TAF/ETV/PEG-IFN with doses); vaccination schedule + HBIG protocol |
| 12–13 | Hepatitis C | Virology; 75–85% chronicity; anti-HCV not protective; DAA regimen table (SOF/VEL, GLE/PIB); SVR = cure; extrahepatic manifestations (cryoglobulinaemia, GN, lymphoma) |
| 14–15 | Hepatitis D & E | HDV satellite virus; co-infection vs superinfection; bulevirtide (EMA-approved); HEV faecal-oral; GT1 maternal mortality 25–30%; ribavirin for chronic GT3 |
| 16–17 | Alcoholic Hepatitis | Disease spectrum (steatosis → HCC); Maddrey formula; Lille score at day 7; prednisolone criteria; pentoxifylline; early transplant |
| 18 | AIH & DILI | AIH types 1/2/3 with antibody profiles; prednisolone + azathioprine; DILI R-ratio classification; paracetamol NAC antidote; RUCAM score |
| 19 | Clinical Approach | History checklist; investigation panel; LFT interpretation guide (AST:ALT ratios, patterns); ALF criteria |
| 20 | Comparison Table | All 5 viruses side-by-side (genome, family, transmission, incubation, chronicity, diagnosis, treatment, vaccine, special feature) |
| 21 | Summary | 7-point key takeaways (one per hepatitis type) |
| 22 | References | Harrison's 22E, Goldman-Cecil, EASL guidelines, AASLD-IDSA HCV guidance 2024 |
This is a shared conversation. Sign in to Orris to start your own chat.